Raaj Medisafe India Ltd
₹ 67.4
-5.00%
10 Dec
- close price
About
Incorporated in 1985, Raaj Medisafe India Ltd manufactures plastic bottles, caps & plugs, plastic liners and aluminum caps
Key Points
- Market Cap ₹ 89.1 Cr.
- Current Price ₹ 67.4
- High / Low ₹ 102 / 63.6
- Stock P/E 11.6
- Book Value ₹ 22.0
- Dividend Yield 0.00 %
- ROCE 15.0 %
- ROE 32.5 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 72.6% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 37.8%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company might be capitalizing the interest cost
- Debtor days have increased from 76.3 to 97.6 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 1.80 | 4.42 | 4.62 | 4.80 | 21.80 | 31.80 | 34.68 | 38.61 | 43.24 | 62.42 | 73.22 | |
| 0.22 | 0.61 | 2.11 | 4.50 | 5.07 | 5.58 | 20.29 | 27.74 | 29.60 | 33.00 | 36.60 | 53.79 | 62.52 | |
| Operating Profit | -0.22 | -0.61 | -0.31 | -0.08 | -0.45 | -0.78 | 1.51 | 4.06 | 5.08 | 5.61 | 6.64 | 8.63 | 10.70 |
| OPM % | -17.22% | -1.81% | -9.74% | -16.25% | 6.93% | 12.77% | 14.65% | 14.53% | 15.36% | 13.83% | 14.61% | ||
| -0.01 | 0.04 | 0.01 | 0.03 | 0.00 | 0.25 | 0.34 | 0.01 | 0.08 | 0.02 | 0.06 | 0.20 | 0.34 | |
| Interest | 0.05 | 0.37 | 0.54 | 0.51 | 0.66 | 0.75 | 1.16 | 0.74 | 0.71 | 1.11 | 1.57 | 2.13 | 2.70 |
| Depreciation | 0.19 | 0.25 | 0.24 | 0.27 | 0.31 | 0.31 | 0.68 | 0.71 | 0.72 | 0.75 | 0.84 | 1.45 | 1.76 |
| Profit before tax | -0.47 | -1.19 | -1.08 | -0.83 | -1.42 | -1.59 | 0.01 | 2.62 | 3.73 | 3.77 | 4.29 | 5.25 | 6.58 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3,100.00% | 12.21% | 19.03% | 11.67% | 22.38% | -16.57% | |
| -0.48 | -1.19 | -1.08 | -0.83 | -1.43 | -1.59 | -0.29 | 2.30 | 3.01 | 3.33 | 3.33 | 6.13 | 7.70 | |
| EPS in Rs | -0.95 | -2.36 | -2.14 | -1.65 | -2.84 | -3.15 | -0.58 | 2.10 | 2.75 | 3.04 | 3.04 | 4.64 | 5.83 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 22% |
| TTM: | 69% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 73% |
| 3 Years: | 27% |
| TTM: | 115% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 41% |
| 3 Years: | 31% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 38% |
| Last Year: | 32% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 10.90 | 10.90 | 10.90 | 10.90 | 10.90 | 13.18 | 13.15 |
| Reserves | -6.49 | -7.96 | -9.03 | -9.88 | -11.32 | -12.91 | -12.09 | -9.83 | -6.75 | -3.41 | -0.07 | 13.74 | 15.96 |
| 4.10 | 7.10 | 7.61 | 9.03 | 9.43 | 11.61 | 11.87 | 13.13 | 13.02 | 15.62 | 25.93 | 34.57 | 52.16 | |
| 0.12 | 0.25 | 1.66 | 1.62 | 2.07 | 1.42 | 2.91 | 2.41 | 2.45 | 2.66 | 4.52 | 7.72 | 7.87 | |
| Total Liabilities | 2.73 | 4.39 | 5.24 | 5.77 | 5.18 | 5.12 | 13.59 | 16.61 | 19.62 | 25.77 | 41.28 | 69.21 | 89.14 |
| 1.41 | 3.30 | 3.57 | 3.49 | 3.47 | 3.48 | 7.03 | 7.26 | 9.30 | 8.63 | 10.72 | 23.06 | 29.38 | |
| CWIP | 0.28 | 0.00 | 0.00 | 0.54 | 0.00 | 0.00 | 0.00 | 1.60 | 0.00 | 1.59 | 10.14 | 8.51 | 15.97 |
| Investments | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| 1.04 | 1.08 | 1.66 | 1.73 | 1.70 | 1.63 | 6.49 | 7.68 | 10.25 | 15.48 | 20.35 | 37.57 | 43.72 | |
| Total Assets | 2.73 | 4.39 | 5.24 | 5.77 | 5.18 | 5.12 | 13.59 | 16.61 | 19.62 | 25.77 | 41.28 | 69.21 | 89.14 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.98 | -0.18 | 0.14 | -0.23 | -0.01 | -1.37 | -1.03 | 2.23 | 2.45 | 0.17 | 4.27 | -0.09 | |
| -0.39 | -2.14 | -0.51 | -0.68 | 0.27 | -0.05 | -0.21 | -2.78 | -0.96 | -1.67 | -13.00 | -16.42 | |
| 1.39 | 2.63 | -0.02 | 0.92 | -0.26 | 1.43 | 1.24 | 0.51 | -1.47 | 1.49 | 8.74 | 16.52 | |
| Net Cash Flow | 0.02 | 0.31 | -0.39 | 0.01 | 0.00 | 0.00 | 0.00 | -0.04 | 0.02 | -0.01 | 0.02 | 0.02 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 115.58 | 35.51 | 60.83 | 62.35 | 78.69 | 56.24 | 57.25 | 64.76 | 66.60 | 97.65 | ||
| Inventory Days | 2,555.00 | 106.92 | 141.13 | 98.61 | 64.61 | 20.96 | 24.65 | 48.18 | 89.79 | 105.50 | 67.86 | |
| Days Payable | 5,475.00 | 538.28 | 233.60 | 275.22 | 132.62 | 51.56 | 19.46 | 6.66 | 10.60 | 8.85 | 35.77 | |
| Cash Conversion Cycle | -315.78 | -56.96 | -115.78 | -5.66 | 48.10 | 61.43 | 98.77 | 143.95 | 163.24 | 129.75 | ||
| Working Capital Days | -56.78 | -87.53 | -141.42 | -123.95 | -7.53 | 8.72 | 4.84 | 36.40 | 21.61 | 9.88 | ||
| ROCE % | -16.47% | -23.41% | -13.99% | -9.06% | -20.94% | -32.01% | 16.41% | 27.09% | 27.99% | 24.23% | 19.58% | 15.02% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - News Paper cutting dated 14.11.2025 for publication of Unaudited Financial Results of the Company for the quarter ended September 30, 2025
-
Unaudited Financial Results -Sept 30, 2025
12 Nov - Unaudited Q2/H1 results for Sep 30, 2025: H1 revenue Rs3,446.95 lakhs; H1 net profit Rs318.72 lakhs.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 12.11.2025
12 Nov - Board approved unaudited results for quarter ended Sep 30, 2025 and Rs.12.00 Crore term loan.
-
Re-Lodgment Of Physical Shares For Transafer
6 Nov - No physical share transfer requests received/re-lodged for period ended Sep 30, 2025; none till Oct 31, 2025.
-
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12.11.2025
5 Nov - Board meeting Nov 12, 2025 to approve Q2 results; related-party deals; Rs.12.00 Cr term loan; bank account shift.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Profile:[1][2]
a) Plastic Bottles
b) Caps & Plugs
c) Plastic Liners
d) Aluminum Caps
e) Disposable Syringes
f) Intravenous Sets
g) Packed Needles